Retail shares rally in post-budget optimism
Subsidies and tax cuts announced in the federal budget could support the outlook for consumer spending, with some analysts looking at the retail sector as a potential beneficiary.
Subsidies and tax cuts announced in the federal budget could support the outlook for consumer spending, with some analysts looking at the retail sector as a potential beneficiary.
Vulcan’s European tick triggers investor rush while Jeanswest goes in administration again. Paladin shares sinks as rain washes away guidance, Whyalla interest boosts BlueScope and rate cut hopes up on Feb inflation fall.
Data shows most active fund managers underperform their benchmarks, so the average person is actually better off investing passively with index funds or ETFs.
WA miner Gold Road hits record amid standoff with rejected suitor, partner Gold Fields. Regal in recovery mode as Opthea questions remain. James Hardie stays in the red after analyst ratings changes. Budget to reveal worsening debt outlook.
The so-called Trump put option may not be completely dead after a report that US tariff announcements next week would be narrower in scope than the US President has threatened.
Building products giant James Hardie’s likely paying too much for US buy. Potential loss of CBA contract hits Helia. Regal dives as pharma group Opthea enters suspension amid survival talks.
The post-Fed meeting rise in shares may say more about market positioning than the interest rate outlook, as trade war prospects threaten economic growth.
TWE on watch as US winemakers now push for tariffs on Australia. Rio joins race for billionaire Mark Creasy’s WA project. Woolworths, Coles mark best day in years after ACCC’s damp squib supermarkets report.
Contrarian investor Alec Cutler thinks US exceptionalism will be put to the test as markets increasingly realise that Donald Trump now cares less about the stock market and economy.
AUD down on 53,000 fewer jobs in Feb. Judo dives as Bain, GIC offload stake. Rinehart-backed Arafura’s best day in almost a year. Red flag raised after $20m withdrawal by Star patrons. Nanosonics is top mid-cap gainer after US FDA tick.
Original URL: https://www.theaustralian.com.au/author/david-rogers